RE:Willow Bio Behind InMed
As an investor, I see intrinsic value/potential in the BioSynthetic Cannabinoid space. My portfolios diiversification of companies within this space refects this. Due to the early stages of this field, it is my belief that success for any of these companies is good for all. I understand that eventually things will get quite competitive between players, but for now I wish success for all Biosynthcann companies...............................especially InMed AND Willow. GLTA (literally)